These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment progress of Duchenne Muscular Dystrophy (DMD)]. Smogorzewska EM; Weinberg KI Med Wieku Rozwoj; 2004; 8(1):25-32. PubMed ID: 15557694 [TBL] [Abstract][Full Text] [Related]
3. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin. Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016 [TBL] [Abstract][Full Text] [Related]
4. Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Duchenne Muscular Dystrophy: Safety and Feasibility Study in India. Rajput BS; Chakrabarti SK; Dongare VS; Ramirez CM; Deb KD J Stem Cells; 2015; 10(2):141-56. PubMed ID: 27125141 [TBL] [Abstract][Full Text] [Related]
5. Patient-tailored application for Duchene muscular dystrophy on mdx mice based induced mesenchymal stem cells. Jeong J; Shin K; Lee SB; Lee DR; Kwon H Exp Mol Pathol; 2014 Oct; 97(2):253-8. PubMed ID: 25102299 [TBL] [Abstract][Full Text] [Related]
6. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation]. Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of myostatin promotes myogenic differentiation of rat bone marrow-derived mesenchymal stromal cells. Geng J; Peng F; Xiong F; Shang Y; Zhao C; Li W; Zhang C Cytotherapy; 2009; 11(7):849-63. PubMed ID: 19903098 [TBL] [Abstract][Full Text] [Related]
8. Different Donors Mesenchymal Stromal Cells Secretomes Reveal Heterogeneous Profile of Relevance for Therapeutic Use. Assoni A; Coatti G; Valadares MC; Beccari M; Gomes J; Pelatti M; Mitne-Neto M; Carvalho VM; Zatz M Stem Cells Dev; 2017 Feb; 26(3):206-214. PubMed ID: 27762666 [TBL] [Abstract][Full Text] [Related]
9. Transplantation of human umbilical cord-derived mesenchymal stems cells for the treatment of Becker muscular dystrophy in affected pedigree members. Li P; Cui K; Zhang B; Wang Z; Shen Y; Wang X; Zhang J; Tong F; Li S Int J Mol Med; 2015 Apr; 35(4):1051-7. PubMed ID: 25647308 [TBL] [Abstract][Full Text] [Related]
10. Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease. Farup J; Madaro L; Puri PL; Mikkelsen UR Cell Death Dis; 2015 Jul; 6(7):e1830. PubMed ID: 26203859 [TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. Gonçalves MA; de Vries AA; Holkers M; van de Watering MJ; van der Velde I; van Nierop GP; Valerio D; Knaän-Shanzer S Hum Mol Genet; 2006 Jan; 15(2):213-21. PubMed ID: 16321987 [TBL] [Abstract][Full Text] [Related]
12. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Liu Y; Yan X; Sun Z; Chen B; Han Q; Li J; Zhao RC Stem Cells Dev; 2007 Oct; 16(5):695-706. PubMed ID: 17999592 [TBL] [Abstract][Full Text] [Related]
13. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro. Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718 [TBL] [Abstract][Full Text] [Related]
14. [Dystrophin and utrophin expression in muscle tissues of DMD mouse model after transplantation treatment by bone marrow mesenchymal stem cells]. Li Z; Zhang C; Xie YM; Chen GJ; Liu XR Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):294-7. PubMed ID: 15266833 [TBL] [Abstract][Full Text] [Related]
15. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Villalta SA; Nguyen HX; Deng B; Gotoh T; Tidball JG Hum Mol Genet; 2009 Feb; 18(3):482-96. PubMed ID: 18996917 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. Giordano C; Mojumdar K; Liang F; Lemaire C; Li T; Richardson J; Divangahi M; Qureshi S; Petrof BJ Hum Mol Genet; 2015 Apr; 24(8):2147-62. PubMed ID: 25552658 [TBL] [Abstract][Full Text] [Related]
17. Generation of skeletal muscle from transplanted embryonic stem cells in dystrophic mice. Bhagavati S; Xu W Biochem Biophys Res Commun; 2005 Jul; 333(2):644-9. PubMed ID: 15946649 [TBL] [Abstract][Full Text] [Related]
18. Clinical use of immunosuppressants in Duchenne muscular dystrophy. Iannitti T; Capone S; Feder D; Palmieri B J Clin Neuromuscul Dis; 2010 Sep; 12(1):1-21. PubMed ID: 20808159 [TBL] [Abstract][Full Text] [Related]
19. Development of therapy for Duchenne muscular dystrophy. Zhang S; Xie H; Zhou G; Yang Z Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471 [TBL] [Abstract][Full Text] [Related]
20. The allure of stem cell therapy for muscular dystrophy. Grounds MD; Davies KE Neuromuscul Disord; 2007 Mar; 17(3):206-8. PubMed ID: 17306535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]